What BD's Quarter ended Jun 30, 2026 10-Q says: 6 signals
BD filed its latest 10-Q with the SEC on Aug 6, 2026. It discusses CRO change, margin pressure and quality issue.
Get BD's live signals in Claude or ChatGPT, or by API
What changed at BD this week? Use Autobound signals for bd.com.- Filed
- Aug 6, 2026
- Period
- Quarter ended Jun 30, 2026
- Filings
- 3
- Signals
- 15
Source: Autobound Signal API · 117 signals tracked for BD · updated
10-Q · latest 10
What BD's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Jun 30, 2026
Filed · 6 signals
BD completed the spin-off of Biosciences and Diagnostic Solutions and restructured its remaining reporting into four segments: Medical Essentials, Connected Care, BioPharma Systems, and Interventional.
BD completed spin-off of Biosciences and Diagnostic Solutions business with Waters Corporation
BD completed the spin-off of its former Biosciences and Diagnostic Solutions business and combination with Waters Corporation on February 9, 2026, receiving a $4 billion cash distribution.
$4B
cash distribution received in connection with the Transaction
BD records gross margin costs and remediation charges to address FDA El Paso Warning Letter
BD's Interventional segment incurred lower gross margins reflecting actions required to respond to the El Paso Warning Letter, alongside $57 million in nine-month product remediation charges.
$57M
product remediation charges recorded in Cost of products sold for the nine-month period
BD incurred $605 million in nine-month restructuring costs under Excellence Unleashed
BD recorded restructuring costs of $48 million for Q3 2026 and $605 million for the nine-month period, including $450 million in asset impairments to exit activities misaligned with its strategy.
Michael Feld identified as Executive Vice President and Chief Revenue Officer
Michael Feld, Executive Vice President and Chief Revenue Officer of BD, adopted a Rule 10b5-1 trading plan on May 27, 2026.
Gross profit margin fell to 46.4% in Q3 2026 due to tariffs and labor costs
Becton Dickinson reported that gross profit margin for the quarter ended June 30, 2026 dropped to 46.4% from 47.3% in the prior-year period.
46.4%
gross profit margin for the three months ended June 30, 2026
- SEC EDGAR
10-Q · Quarter ended Mar 31, 2026
Filed · 4 signals
BD Reorganizes Into Four Worldwide Segments Following Separation of Life Sciences Business
BD eliminated the Life Sciences segment post-separation and reorganized operations into four worldwide segments: Medical Essentials, Connected Care, BioPharma Systems, and Interventional, while also separating EMEA into Europe and META.
BD completed the spin-off and combination of its former Biosciences and Diagnostic Solutions business with Waters Corporation in a Reverse Morris Trust transaction, receiving a $4 billion cash distribution.
$4B
cash distribution received in connection with the Transaction
BD recorded $487 million in restructuring costs including $450 million asset impairment
Becton Dickinson incurred $487 million in restructuring costs for Q2 2026, driven by $450 million in non-cash asset impairment charges upon committing to exit operational activities and projects under its 'Excellence Unleashed' strategy.
BD split EMEA into distinct Europe and META operational sales regions
Effective fiscal 2026, BD split its former EMEA region into Europe and META (Middle East, Turkey, and Africa) to realign sales and distribution.
Earlier 10-Q filings
- 10-Q · Quarter ended Dec 31, 2025Filed · 5 signalsSEC EDGAR
Showing 10 of 15 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
BD earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Committing $19B US investment with $3B manufacturing expansionUnder a landmark partnership with the U.S. government, investments are being reprioritized domestically to strengthen manufacturing capacity and supply chain resilience. The agreement also provides potential relief from future Section 232 tariffs on covered medical technologies. Key manufacturing hubs include sites in Columbus, Nebraska, El Paso, Texas, and Sumter, South Carolina. | |
| Achieved 100% identification on $200M cost savings programThe company identified 100% of savings from its $200 million cost-out program launched in fiscal 2026. Operational execution was driven by plant gross productivity of approximately 8% and over 2,000 Kaizen events under the continuous improvement operating model. | |
| Deploying Cognite industrial AI across manufacturing plant networkThe company has begun standardizing on the Cognite platform across its manufacturing facilities to automate demand forecasting, production scheduling, and inventory optimization. This rollout enables consolidation and retirement of disparate legacy platforms across the global IT and operations tech stack. | |
| Absorbed 90 basis points operating margin tariff headwindTariffs created a 90 basis points drag on adjusted operating margins for the full year of fiscal 2026. While the company received tariff refunds that were deployed into share buybacks, forward guidance assumes tariff levels persist in line with fiscal 2026 pending finalization of Section 232 actions. | |
| Appointed Art Hu as Chief Information Officer from LenovoArt Hu was recruited from Lenovo as the company's new Chief Information Officer to accelerate digital transformation and AI integration across commercial, operational, and administrative operations. New CIO appointments often trigger vendor rationalization and strategic evaluations of IT enterprise software stacks. | |
| Reallocated digital R&D resources into Connected Care unitAll central digital R&D resources were transferred into Connected Care, accompanied by the establishment of a dedicated Artificial Intelligence Center of Excellence in Irvine, California. The move aligns software, digital, and AI research closer to key commercial platforms such as Advanced Patient Monitoring and Pyxis. |
Signal API · MCP
Track BD with the Signal API
One POST /v1/companies/enrich call with bd.com returns BD 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bd.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about BD 10-Q
When did BD file its latest 10-Q?
What did BD disclose in its latest 10-Q?
What did BD say on its recent earnings calls?
Where can I read BD's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .